GoHealthcare MSK Specialty Procedure Library™ | Lumbar Fusion Procedures
Extreme Lateral Interbody Fusion (XLIF / LLIF)
Developed by Pinky Maniri, Founder & Chief Executive Officer, GoHealthcare Practice Solutions
Clinical, coverage, medical necessity, prior authorization, documentation, coding, reimbursement, denial prevention, and operational guidance for MSK specialty teams.
This evergreen operational reference is designed for physicians, APPs, prior authorization teams, utilization management nurses, practice administrators, revenue cycle professionals, ASCs, hospitals, and healthcare executives. Verify current patient-specific payer, coding, clinical, and site-of-service requirements before use.
Up to 98%
Company-reported prior authorization approval performance in managed workflows. Results vary by payer, procedure, documentation quality, benefit design, and client implementation.
01
Coverage, Documentation & Operations
Evidence at a Glance
Extreme lateral interbody fusion (XLIF) - the branded name for the lateral transpsoas variant of lateral lumbar interbody fusion (LLIF) - reaches the disc space through a lateral retroperitoneal corridor that traverses the psoas muscle. It permits placement of a wide interbody implant that restores disc height and provides indirect decompression and coronal correction without an anterior great-vessel dissection or a posterior muscle-stripping approach. Its defining operational features are a mandatory neuromonitoring workflow, a level range that excludes L5-S1, and lumbar-plexus morbidity unique to crossing the psoas.
| Domain | Summary (verify against current payer policy & date of service) |
|---|---|
| Primary CPT® | 22558 (anterior/anterolateral interbody arthrodesis, single interspace, lumbar); +22585 each additional interspace. The lateral approach does not have a distinct arthrodesis code. |
| Neuromonitoring | Transpsoas access relies on intraoperative neuromonitoring (IONM); +95940 / +95941 / G0453 are separately reportable only when performed by a dedicated monitoring professional, not the operating surgeon. |
| Access range | Lateral corridor reaches roughly T12/L1 to L4/5; L5-S1 is not accessible laterally (iliac crest), so multilevel constructs often pair XLIF with ALIF or a posterior technique at L5-S1. |
| Medicare NCD / LCD | No NCD specific to lumbar fusion. MAC LCDs (e.g., L37848; historical L33382) require documented spondylolisthesis and/or instability; fusion for isolated DDD is generally non-covered. |
| 2026 site-of-service | As part of the CY2026 IPO-list phase-out (musculoskeletal-first), 22558 was among the fusion codes CMS identified for IPO removal / ASC-CPL addition. Confirm 22558's final OPPS Addendum B / ASC Addendum AA status at the date of service. |
| Commercial PA | Required by essentially all commercial and Medicare Advantage plans; frequently delegated to eviCore (CMM-609), Carelon, Cohere, Evolent, or TurningPoint. |
| Conservative therapy | Typically 6 weeks to 6 months of documented, failed, structured non-operative care (payer- and device-label-dependent; lateral device labels commonly specify at least 6 months). |
| Imaging / instability | MRI or CT plus weight-bearing flexion/extension radiographs when instability is the indication; standing/coronal alignment films where deformity correction is a goal. |
| Biologic note | rhBMP-2 (Infuse) is on-label only for single-level anterior ALIF; use in a lateral (transpsoas) fusion is off-label and payer-restricted. |
| Typical approval driver | A clear, imaging-correlated instability, listhesis, or coronal/deformity-correction rationale tied to failed conservative care - not axial back pain alone. |
Terminology. "XLIF" is a registered trademark (originating with NuVasive, now Globus Medical); "LLIF" is the generic descriptor for the lateral transpsoas approach, and related variants include DLIF (direct lateral) and pre-psoas approaches. This guide applies to the lateral transpsoas technique generally; device names are used for identification only. How to use this guide. Every code and policy statement should be re-verified at the point of care.
02
Coverage, Documentation & Operations
Procedure Overview
XLIF/LLIF approaches the lumbar disc from the side, through a retroperitoneal corridor and across (or, in pre-psoas variants, around) the psoas muscle. After the disc is removed, a wide interbody spacer is seated on the dense apophyseal ring at both endplate margins, restoring disc height and segmental and coronal alignment. Because the tall, wide implant reliably restores disc and foraminal height, XLIF provides indirect neural decompression, often avoiding a direct posterior decompression. The technique is well suited to multilevel degenerative and deformity work where coronal correction and indirect decompression are goals.
Two features dominate the operational profile. First, the transpsoas corridor passes through the lumbar plexus, which lies within the substance of the psoas; this mandates intraoperative neuromonitoring and drives an approach-specific morbidity profile. Second, the iliac crest blocks lateral access to L5-S1, so the corridor is practically limited to roughly T12/L1 through L4/5; L5-S1, when it must be addressed, is typically fused through an anterior (ALIF) or posterior approach in the same or a staged setting. XLIF may be performed stand-alone, with a lateral plate, or supplemented with posterior pedicle-screw fixation.
GOHEALTHCARE CLINICAL INSIGHTS - THREE THINGS THAT MAKE XLIF DIFFERENT
Relative to ALIF and posterior interbody fusions, an XLIF record must account for three distinctive elements: (1) the neuromonitoring service and who performed it (bundled if the surgeon, separately reportable only if a dedicated professional); (2) the level range - a request that lists L5-S1 as a lateral level should prompt a second look, because the iliac crest generally precludes it; and (3) the indirect-decompression rationale, which must be documented when no direct decompression is performed. Capturing these up front prevents the most common XLIF-specific authorization and claim problems.
03
Coverage, Documentation & Operations
Relevant Anatomy (High-Level)
Only the anatomy needed to understand indications, documentation, coverage, and approach risk is summarized here; this guide is not a surgical atlas.
n Lateral disc space and apophyseal ring. The lateral target; seating a wide implant on the dense ring margins restores disc height and resists subsidence. n Psoas muscle and lumbar plexus. The lumbar plexus (L1-L4 roots) forms within the posterior portion of the psoas; the transpsoas corridor risks the femoral and genitofemoral nerves and the plexus, which is why neuromonitoring is integral. n Iliac crest. Blocks lateral access to L5-S1 and constrains access at L4-5, defining the practical level range (T12/L1 to L4/5). n Great vessels and their migration. At more caudal levels the iliac vessels course more laterally and the plexus more anteriorly, narrowing the safe lateral window and raising injury risk. n Neural foramen. Restoring disc height indirectly decompresses the foramen, the mechanistic basis for XLIF without a direct posterior decompression. n Coronal and sagittal alignment. The lateral approach is a powerful tool for coronal (scoliosis) correction and, with anterior longitudinal ligament release, sagittal correction - making alignment parameters relevant to planning and coverage.
04
Coverage, Documentation & Operations
Clinical Indications
XLIF/LLIF is generally indicated when a structural, segmental problem in the accessible range produces concordant, disabling symptoms unresponsive to appropriate non-operative care, and where a lateral approach offers advantages in indirect decompression or coronal correction. Commonly accepted indications (mirroring lateral-device FDA labeling) include:
n Degenerative disc disease (discogenic back pain with radiographically confirmed degeneration) at accessible levels, with instability or as part of a reconstructive strategy. n Degenerative spondylolisthesis (typically low grade) with instability. n Degenerative scoliosis / coronal deformity , where the lateral approach enables powerful coronal correction across multiple levels. n Adjacent-segment disease above a prior fusion. n Spinal stenosis amenable to indirect decompression through disc-height restoration, in the setting of instability. n Symptomatic pseudarthrosis (failed prior fusion) at an accessible level.
WATCH-OUTS - LEVEL AND INDICATION LIMITS
L5-S1 cannot be reached laterally because of the iliac crest; a request listing L5-S1 as an XLIF level is a red flag. Isolated axial back pain from degenerative disc disease without instability or a defined reconstructive goal remains payer-scrutinized. Direct decompression for high-grade central stenosis or a sequestered fragment is not achieved by indirect decompression alone - document the decompression strategy. Anterior longitudinal ligament (ALL) release for sagittal correction adds vascular and neurologic risk and should be explicitly justified.
05
Coverage, Documentation & Operations
Patient Selection
Durable outcomes and clean authorizations depend on selecting patients whose pathology, symptoms, modifiable risk profile, and lateral corridor anatomy align. Selection factors reviewers and surgeons weigh:
n Target levels within the accessible range (roughly T12/L1 to L4/5); a separate plan for L5-S1 if it must be addressed. n Favorable psoas and lumbar-plexus anatomy on axial imaging (psoas morphology, plexus position, vessel course), particularly at L4-5. n Concordance between imaging, examination, and symptoms; a documented, failed, structured course of conservative care. n Indication suited to indirect decompression, or a documented plan for direct decompression where needed. n Absence of prohibitive prior retroperitoneal surgery / adhesions on the approach side. n Nicotine / tobacco status with cessation counseling; bone-density status (osteopenia/osteoporosis affects subsidence risk and fixation strategy). n Body mass index, diabetic control, and other comorbidities; realistic expectations and rehabilitation capacity.
06
Coverage, Documentation & Operations
Contraindications
Absolute / near-absolute
n L5-S1 as the sole intended lateral target (iliac crest precludes lateral access - use an alternative approach). n Active local or systemic infection (unless fusion is being performed to treat spinal infection). n Retroperitoneal anatomy precluding safe lateral access (prohibitive adhesions, unfavorable vessel/plexus configuration). n Medical instability precluding a major spine operation.
Relative / conditional
n Unfavorable psoas / lumbar-plexus anatomy at the target level (especially L4-5). n Uncorrected severe osteoporosis (subsidence risk; address before or concurrently). n Active nicotine use (many policies and device labels require cessation/counseling). n High-grade spondylolisthesis or pathology requiring direct decompression not achievable indirectly. n Absence of a structural target - pain without instability or a defined reconstructive goal. n Prior ipsilateral retroperitoneal surgery.
07
Coverage, Documentation & Operations
Conservative Treatment Requirements
Payers - and lateral-device FDA labeling, which commonly specifies at least six months of non-operative treatment condition elective XLIF approval on documented, failed conservative care. The record should show structured care that was actually trialed:
n Activity modification and a supervised or prescribed physical therapy program, with dates, duration, and response. n Pharmacologic management appropriate to the diagnosis, with response documented. n Interventional procedures where clinically appropriate (for example, epidural steroid injection), with dates and outcomes. n Home exercise, bracing, or activity-based programs where relevant. n A clear statement that symptoms and functional impairment persisted despite the above.
GOHEALTHCARE PRIOR AUTHORIZATION INSIGHT - MAKE CONSERVATIVE CARE AUDIT-PROOF
The most avoidable fusion denial is a conservative-care timeline a reviewer cannot reconstruct. Capture the modality, the start and end dates, the provider, and the measured response for each trial. For XLIF specifically, note that many lateral-device labels reference a six-month non-operative threshold - aligning the documented conservative-care duration with both the payer criterion and the device label removes an easy denial and a compliance gap in one step.
08
Coverage, Documentation & Operations
Imaging Requirements
Imaging must establish the structural diagnosis, the dynamic component where instability is claimed, and - uniquely for XLIF - the lateral corridor and plexus anatomy. Expect payers and surgeons to require:
n MRI of the lumbar spine (or CT / CT-myelogram when MRI is contraindicated) demonstrating level-concordant pathology. n Axial imaging of the psoas and lumbar plexus / vessels at the target level to assess corridor safety (especially at L4-5). n Weight-bearing flexion / extension radiographs when instability or spondylolisthesis is the indication. n Standing / coronal (scoliosis) and sagittal-alignment films where deformity or coronal correction is part of the rationale. n A radiology report and, ideally, the treating surgeon's correlation of imaging to symptoms, exam, and the chosen lateral approach.
WATCH-OUTS - IMAGING PITFALLS THAT TRIGGER DENIALS
Submitting only supine MRI for an instability-based request is a common miss. For XLIF, also confirm the target level is laterally accessible and that the psoas/plexus anatomy supports a transpsoas corridor - an L5-S1 lateral request or an unfavorable plexus position invites clinical review. Indirect decompression must be justified by the imaging showing recoverable disc/foraminal height.
09
Coverage, Documentation & Operations
Medical Necessity
Medical necessity for XLIF is built, not asserted. The record should demonstrate a logical chain from structural pathology to disabling, concordant symptoms, through failed conservative care, to a fusion whose specific goal (stabilization, indirect decompression, coronal/deformity correction) is stated, at a level the lateral approach can reach. Elements reviewers weigh most heavily:
n A specific structural diagnosis with level(s) and, for listhesis, grade; for deformity, the coronal/sagittal parameters. n Concordant symptoms and objective examination findings. n Imaging that corroborates the diagnosis at the level to be fused and confirms lateral accessibility. n A documented, dated, failed course of appropriate conservative care (commonly six months for lateral-device indications).
n A rationale for the lateral approach specifically (indirect decompression, coronal correction, access advantages), and a decompression plan where indirect decompression is insufficient. n An explicit medical-necessity statement authored by the operating surgeon.
GOHEALTHCARE LEADERSHIP PERSPECTIVE - INDIRECT DECOMPRESSION IS A DOCUMENTATION DISCIPLINE
XLIF's central value proposition - achieving neural decompression indirectly by restoring disc and foraminal height is also its central documentation challenge. When no direct decompression is performed, a reviewer sees a fusion without a decompression code and may question how the neural compression was addressed. The instability pivot that governs all lumbar fusion coverage (supported by SLIP and tempered by the decompression-alone non-inferiority signal in Forsth and NORDSTEN-DS) still applies; XLIF adds a second necessity axis in coronal and deformity correction. The operational lesson is to state explicitly, in the surgeon's own words, that disc-height restoration will indirectly decompress the symptomatic foramen or recess, supported by the imaging - converting an implicit mechanism into an explicit, reviewable rationale.
10
Coverage, Documentation & Operations
Documentation Requirements
Use the following as a pre-submission checklist. Each item that is present, dated, and specific reduces the probability of a request for information, a peer-to-peer, or a denial.
n Chief complaint and symptom duration, with functional impact (e.g., ODI or documented activity limitation) n Pain characterization and distribution (axial vs. radicular vs. claudicant) n Focused neurological examination (motor, sensory, reflexes, provocative signs) n Specific structural diagnosis with level(s); for listhesis, grade; for deformity, coronal/sagittal parameters n MRI or CT correlated to the symptomatic level, plus axial psoas/plexus assessment at the target level n Weight-bearing flexion/extension radiographs when instability is the indication; coronal/alignment films for deformity n Confirmation the target level is laterally accessible (not L5-S1) n Itemized, dated conservative-care ledger with measured response (commonly six months for lateral indications) n Explicit indirect-decompression rationale, or a documented plan for direct decompression n Nicotine/tobacco status and cessation counseling; bone-density status where relevant n Neuromonitoring plan and the identity/role of the monitoring professional (for correct IONM reporting) n Planned levels, standalone vs. lateral-plate vs. supplemental posterior fixation, interbody device, graft/biologic n Explicit surgeon medical-necessity statement and site-of-service rationale
11
Coverage, Documentation & Operations
Device Manufacturers & System Considerations
XLIF is device-intensive; the guide addresses the lateral implant landscape at an operational level. Mention of specific manufacturers is for identification only and is not an endorsement.
Lateral interbody spacers
| Category | Representative systems / notes |
|---|---|
| Static lateral cages (PEEK / titanium / porous Ti) | Wide footprint seated on the apophyseal ring (e.g., Globus/NuVasive CoRoent XL, RISE-L, Modulus XLIF 3D-printed porous titanium, Cohere XLIF; Medtronic direct-lateral systems). Porous/3D-printed titanium adds osteoconductive surface; radiodense implants may obscure intra-cage fusion assessment. |
| Expandable lateral cages | In-situ height/lordosis adjustment to reduce over-distraction and subsidence (e.g., Caliber-L, XLX ACR). Higher unit cost and a device-intensive consideration in outpatient settings. |
| Category | Representative systems / notes |
|---|---|
| Lateral plates | Low-profile anti-migration plates for stand-alone or supplemental lateral fixation, and for anterior longitudinal ligament compromise (e.g., ADIRA / Modulus XLIF Plate). |
Fixation strategy
XLIF may be performed stand-alone, with a lateral plate, or supplemented with posterior pedicle-screw instrumentation. Posterior fixation, when added, is reported with the posterior instrumentation codes; a lateral plate is reported with the anterior instrumentation codes. The choice among stand-alone, lateral-plate, and posterior supplementation is a clinical judgment influenced by level, listhesis grade, deformity, and bone quality (subsidence risk).
Biologics
n
Allograft, autograft, demineralized bone matrix, ceramics, and cellular bone matrices are used to fill the wide
lateral cage. n rhBMP-2 (Infuse) is off-label for lateral fusion - its FDA approval is limited to single-level anterior ALIF with a specified cage. Off-label lateral use is payer-restricted and should be documented with rationale and consent.
FDA labeling & MRI conditionality
n Lateral interbody devices are generally cleared for skeletally mature patients across L1-L5 for indications such as DDD, spondylolisthesis, deformity, stenosis, and failed prior fusion, typically after at least six months of non-operative treatment and used with supplemental fixation as indicated. n Most contemporary titanium and PEEK constructs are labeled MR Conditional ; the specific conditions live in the manufacturer's IFU and should be captured for downstream imaging. n Confirm the device's coverage status and on-label level/indication, not just its clearance.
GOHEALTHCARE CLINICAL INSIGHTS - SUBSIDENCE, DEVICE CHOICE, AND THE ASC MATH
Two device decisions drive avoidable problems. First, bone quality and endplate purchase: in osteopenic patients, cage footprint, expandable-device over-distraction, and supplemental fixation all bear on subsidence, and the plan should reflect that. Second, device-intensive and expandable lateral implants migrating into an ASC under the 2026 rules: model the device offset and cost-per-case before shifting the site of service, and confirm the center's neuromonitoring capability, since IONM is integral to a safe transpsoas case.
Strengthen Authorization and Revenue Integrity
GoHealthcare helps MSK specialty organizations align documentation, payer criteria, coding, scheduling, and denial-prevention workflows.
12
Policy, Evidence & Source Guidance
CMS / Medicare Coverage
There is no National Coverage Determination specific to lumbar interbody fusion. Coverage is shaped by (1) MAC LCDs and articles, (2) the OPPS/ASC payment framework and the Inpatient-Only transition, and (3) the 2-midnight rule. Because XLIF is reported with the anterior/anterolateral arthrodesis code 22558, the same CMS considerations that apply to anterior lumbar fusion apply here. Key points for 2026:
n LCDs. Several MACs maintain lumbar-fusion LCDs (for example, L37848 Lumbar Fusion; the earlier L33382). These generally cover fusion for documented spondylolisthesis or instability and treat fusion for isolated degenerative disc disease as not medically necessary; investigational devices/techniques are commonly excluded. n Inpatient-Only phase-out. In the CY2026 OPPS/ASC Final Rule, CMS finalized eliminating the IPO list over a three-year transition beginning with musculoskeletal procedures - removing roughly 285 codes and adding hundreds of codes to the ASC Covered Procedures List. 22558 (which reports XLIF/LLIF) was among the anterior fusion codes CMS identified for this move; published summaries most often cite the posterior codes (22630/22633) as spine examples. Confirm 22558's final status directly in OPPS Addendum B and ASC Addendum AA at the date of service. n Neuromonitoring coverage. IONM has its own MAC coverage articles (e.g., billing/coding article A56722); when separately reported, it must meet the dedicated-professional and time requirements. This is a distinct coverage stream from the fusion itself.
n Site of service is a clinical decision. Removal from the IPO list does not require outpatient performance; the surgeon documents why inpatient, HOPD, or ASC is appropriate, and the setting must support neuromonitoring and the approach. n 2-midnight rule. When inpatient admission is planned, the record must support an expected stay crossing two midnights or otherwise justify inpatient status.
WATCH-OUTS - THE 2026 SITE-OF-SERVICE TRAP
The IPO change is an opportunity and a liability. Commercial and Medicare Advantage plans may now steer lateral fusion to lower-cost sites and deny inpatient stays that are not clearly justified. An ASC performing a newly eligible lateral fusion must confirm device-intensive payment, neuromonitoring capability, and clinical readiness. Do not assume prior inpatient defaults still apply - re-verify per patient, per payer, per date of service, and confirm 22558's final Addendum AA/B status.
13
Policy, Evidence & Source Guidance
Commercial Payer Comparison
Commercial and Medicare Advantage plans almost universally require prior authorization for lumbar fusion and most delegate the clinical review to a specialty utilization-management vendor. Criteria are broadly similar in structure instability or listhesis, concordant imaging, failed conservative care, risk-factor documentation - but differ in thresholds. Synthesized, not reproduced:
| Reviewer / policy | Emphasis & notable elements (verify current version) |
|---|---|
| eviCore (CMM-609 Lumbar Fusion) | One guideline covers anterior, lateral, posterior, and combined approaches; criteria keyed to spondylolisthesis grade (Meyerding), anterolisthesis on imaging, documented instability, and failed conservative care; nicotine-free status documentation is a recurring requirement. |
| Carelon (Spine Surgery) | Degenerative spondylolisthesis with a fixed anterolisthesis or dynamic movement (on the order of 3 mm) on flexion/extension films plus symptoms/impairment not responding to at least ~6 weeks of conservative care; osteopenia/osteoporosis (DEXA T-score at or below -1.0) and implant-material allergy are cautionary/exclusionary. |
| Cohere Health | Digital intake with real-time criteria; instability, imaging correlation, and conservative-care history mirror the common framework; completeness at intake drives auto-approval. |
| Evolent / TurningPoint | MSK surgical UM programs applying comparable instability-plus-conservative-care logic; used by select regional and Medicaid plans. |
| UnitedHealthcare | Commercial spine PA plus a Medicare Advantage spine-procedures policy; documented instability/listhesis and neural-compression correlation required; IONM has its own policy. |
| Aetna (CPB 0743 / 0016) | CPB 0743 supplements LCD L37848 and requires radiologic evidence of neural compression; interbody-device policy (CPB 0016) ties cage coverage to meeting the fusion criteria; fusion for DDD listed as not medically necessary. |
| Cigna (via eviCore) / Humana / BCBS | Cigna applies eviCore CMM-609; Humana and BCBS plans (e.g., Premera 7.01.542) track the common instability-plus-failed-care framework. |
Common threads and an XLIF-specific note. Across payers: instability, listhesis, or a defined reconstructive/deformity goal - not stenosis or axial pain alone - is the fusion pivot; dynamic imaging is expected when instability is claimed; a dated, structured conservative-care history is mandatory. For XLIF, also expect scrutiny of the indirect-decompression rationale when no direct decompression is coded, and remember that intraoperative neuromonitoring is adjudicated under a separate policy . Always confirm which vendor holds the delegation for the specific plan and product before submitting.
14
Coverage, Documentation & Operations
Prior Authorization Workflow
A repeatable, front-loaded workflow is the difference between a first-pass approval and a cycle of information requests and peer-to-peer reviews. A representative end-to-end path:
n
- Verify benefits & delegation. Confirm the plan/product, that fusion requires PA (it almost always does), which
UM vendor holds the review, and whether neuromonitoring requires separate authorization. n
- Assemble the packet. Surgeon note with the structural diagnosis and levels, correlated MRI/CT with axial
psoas/plexus assessment, flexion/extension and (for deformity) coronal films, the itemized conservative-care ledger, the indirect-decompression rationale, and the medical-necessity statement. n
- Map to the criteria. Walk the record against the specific vendor's criteria and fill gaps before submitting -
including confirming lateral accessibility of the target level. n
- Address neuromonitoring. Confirm the IONM arrangement and reporting professional so the monitoring claim is
set up correctly and, where required, separately authorized. n
- Submit & document. Submit through the required channel; record the authorization/reference number, the
criteria version, and the reviewer. n
- Manage clinical review / peer-to-peer. Prepare the surgeon with the instability or deformity narrative, the
indirect-decompression rationale, and the conservative-care timeline. n
- Confirm site of service & codes. Ensure the authorized CPT® set matches the plan (primary, add-on levels,
lateral-plate vs. posterior instrumentation, interbody device, graft) and that the site supports neuromonitoring. n
- Schedule, re-verify & close the loop to billing. Confirm the authorization is active for the scheduled date; hand
off the authorization, approved codes, IONM arrangement, and site to revenue cycle so the claim matches exactly.
15
Coverage, Documentation & Operations
Common Prior Authorization Denials
The recurring denial patterns for XLIF are predictable and therefore preventable:
n Insufficient conservative care. Duration not met (note the common six-month lateral-device threshold), or the trial is described but not dated/itemized. n No documented instability or reconstructive goal. Fusion requested for axial pain or DDD without listhesis, dynamic imaging, or a defined coronal/deformity objective. n Missing dynamic or alignment imaging. Instability or deformity claimed without the supporting films. n Level inaccessibility. L5-S1 listed as a lateral level, or a target the lateral corridor cannot reach. n Unjustified indirect decompression. Neural compression not shown to be addressable by disc-height restoration, with no direct decompression planned. n Non-covered indication. Isolated discogenic pain; investigational device or technique. n Neuromonitoring denial. IONM billed by the surgeon (bundled), or without the dedicated-professional/time documentation. n Code or site mismatch. Authorized levels/codes, instrumentation type, or site do not match the operative plan.
16
Coverage, Documentation & Operations
Appeal Strategies
Effective appeals answer the specific denial rationale with specific, dated documentation - they do not restate the original request. Practical approach:
n Read the denial reason literally and rebut that exact point (e.g., dynamic instability measurements; the coronal deformity parameters; the indirect-decompression mechanism). n Supply the dated conservative-care ledger if the denial cites insufficient non-operative care. n Add the surgeon's correlation letter tying imaging to symptoms and exam and explaining the lateral approach and how decompression is achieved.
n Separate the neuromonitoring appeal where the denial concerns IONM - it is adjudicated under its own policy and requires the dedicated-professional/time documentation. n Cite the applicable policy back to the payer and prepare a concise, two-minute peer-to-peer summary. n Escalate methodically through reconsideration and external / independent review, tracking timely-filing deadlines.
GOHEALTHCARE BEST PRACTICES - PREVENT THE PEER-TO-PEER
The most efficient appeal is the one never needed. Route every fusion request through a single pre-submission checklist mapped to the specific vendor's criteria - instability or reconstructive goal documented, dynamic/coronal imaging attached, conservative care itemized, target level confirmed accessible, indirect-decompression rationale stated, neuromonitoring arrangement clarified, and a surgeon medical-necessity statement included. This converts the majority of would-be peer-to-peer reviews into first-pass approvals.
17
Coding, Billing & Revenue Integrity
Coding & Billing Overview
This is an operational coding orientation, not a reimbursement or NCCI-edit manual; detailed payment methodology belongs to the GoHealthcare Revenue Cycle Knowledge Center. Key principles for XLIF:
n XLIF/LLIF is reported with the anterior/anterolateral interbody arthrodesis code 22558 (single interspace, lumbar) there is no distinct lateral code; +22585 is added for each additional interspace. n The minimal discectomy intrinsic to interspace preparation is included in the arthrodesis and is not separately reported. n The interbody device (+22853) and bone graft are reported with their own add-on codes. n A lateral plate is reported with the anterior instrumentation codes (22845 for 2-3 vertebral segments, 22846 for 4-7, 22847 for 8+). When XLIF is supplemented with posterior pedicle-screw fixation, the posterior instrumentation codes (e.g., 22840 non-segmental, 22842 segmental) apply per the operative note. n Intraoperative neuromonitoring (+95940 one-on-one in the operating room, per 15 minutes; +95941 or Medicare G0453 for remote/nearby monitoring) is reported only by a dedicated monitoring professional. If the operating surgeon or anesthesiologist performs the monitoring, it is bundled into the primary service and not reported separately. Modifiers TC/26 do not apply to these codes. n The same 22558 code also reports ALIF and OLIF; the specific corridor is documented in the operative note, not distinguished by a different arthrodesis code. n Place of service and ASC eligibility shifted for 2026 (see CMS section); the claim's site must match the authorization.
18
Coding, Billing & Revenue Integrity
Applicable CPT Codes
| Code | Descriptor (abbreviated) | Role in XLIF/LLIF |
|---|---|---|
| 22558 | Arthrodesis, anterior interbody technique, incl. minimal discectomy to prepare interspace (other than for decompression); lumbar | Primary code (also ALIF/OLIF) |
| +22585 | Each additional interspace; lumbar | Add-on for each additional level |
| +22853 | Insertion of interbody biomechanical device (e.g., cage/mesh) in conjunction with interbody arthrodesis, each interspace | Lateral interbody spacer add-on |
| +22845 / +22846 / +22847 | Anterior instrumentation; 2-3 / 4-7 / 8+ vertebral segments | Lateral-plate construct add-on |
| +22840 / +22842 | Posterior non-segmental / segmental (3-6 segments) instrumentation | When supplemented with posterior fixation |
| Code | Descriptor (abbreviated) | Role in XLIF/LLIF |
|---|---|---|
| +95940 | Continuous IONM in the operating room, one-on-one, each 15 min | Neuromonitoring (dedicated professional only) |
| +95941 / G0453 | Continuous IONM from outside the OR (remote/nearby); G0453 for Medicare | Neuromonitoring reader (dedicated professional only) |
| +20936 / +20937 / +20938 / 20930 / 20931 | Autograft (local / separate incision / structural) / allograft (morselized / structural) | Bone graft add-on codes |
Codes are listed for operational orientation and must be verified against the current CPT® code set, payer policy, and NCCI edits before submission. Add-on codes are reported in addition to the primary procedure and are exempt from modifier 51. Neuromonitoring performed by the operating surgeon is not separately reportable.
19
Coverage, Documentation & Operations
HCPCS Codes (When Applicable)
For most physician (professional) claims, the fusion is captured by the CPT® set above. On the neuromonitoring side, G0453 is the Medicare reader code used in place of +95941 for remote/nearby monitoring. On the facility side (hospital outpatient / ASC), HCPCS Level II codes may appear for device and biologic reporting, and pass-through or device-category C-codes may apply to specific lateral implants in the OPPS/ASC setting. Because device and IONM coding are setting- and date-specific, confirm the current facility HCPCS/C-code, the applicable IONM reader code, and any device-intensive designation with the facility's chargemaster and the payer at the date of service.
20
Coding, Billing & Revenue Integrity
Common ICD-10-CM Diagnosis Codes
Diagnosis selection must be specific to region and to the documented clinical detail. The codes below are frequently applicable to XLIF indications and were confirmed as billable for the current fiscal year (valid through 09/30/2026); always code to the documentation.
| ICD-10-CM | Description | Note |
|---|---|---|
| M43.16 | Spondylolisthesis, lumbar region | Billable |
| M43.17 | Spondylolisthesis, lumbosacral region | Billable |
| M48.061 | Spinal stenosis, lumbar region, without neurogenic claudication | Billable; parent M48.06 is NOT billable |
| M48.062 | Spinal stenosis, lumbar region, with neurogenic claudication | Requires documented claudication, not imaging alone |
| M51.16 | Intervertebral disc disorder with radiculopathy, lumbar region | Billable |
| M51.26 | Other intervertebral disc displacement, lumbar region | Herniation without myelopathy/radiculopathy |
| M51.36 | Other intervertebral disc degeneration, lumbar region | DDD alone rarely supports fusion |
| M41.86 / M41.26 | Other forms of scoliosis, lumbar region / other idiopathic scoliosis, lumbar region | Degenerative / adult scoliosis (deformity context) - code to type & site |
| M53.2X6 / M53.2X7 | Spinal instabilities, lumbar / lumbosacral region | Code to the documented site of instability |
| M96.0 | Pseudarthrosis after arthrodesis or fusion | Failed prior fusion (revision context) |
Avoid non-billable parent codes (for example, M48.06 for lumbar stenosis requires the 5th/6th-character specificity of M48.061 or M48.062). Match the region to the operative level, and verify scoliosis-code specificity (type and site) against the documentation, as the M41 series is granular.
21
Coding, Billing & Revenue Integrity
Applicable Modifiers
| Modifier | Use in the XLIF/LLIF context |
|---|---|
| -51 | Multiple procedures (add-on codes, including instrumentation and IONM, are exempt from -51). |
| -59 / X{EPSU} | Distinct procedural service - e.g., a separately reportable service at a different level; use the most specific X modifier where required. |
| -62 | Two surgeons (co-surgeons) - less common than in ALIF but applicable when two surgeons each perform a distinct part of the procedure and each dictates an operative note. |
| -22 | Increased procedural services - only with explicit documentation of substantially greater work; typically applied to the primary code. |
| -80 / -82 | Assistant surgeon / assistant when a qualified resident is unavailable, per payer rules. |
| TC / 26 | Do not apply to the IONM codes +95940 / +95941 / G0453; the technical component is the facility's responsibility and these are professional-time codes. |
| -58 / -78 / -79 | Staged/related/unrelated procedure during the global period (e.g., staged L5-S1 via another approach, or revisions). |
22
Coverage, Documentation & Operations
Clinical Documentation Checklist
A consolidated, pre-submission checklist for the authorization packet and the operative-note handoff to coding:
n Structural diagnosis with level(s); for listhesis, grade; for deformity, coronal/sagittal parameters n Concordant symptom description with duration and neurological examination findings n MRI/CT correlated to the symptomatic level, plus axial psoas/plexus assessment at the target n Confirmation the target level is laterally accessible (not L5-S1) n Weight-bearing flexion/extension radiographs for instability; coronal/alignment films for deformity n Itemized, dated conservative-care ledger (commonly six months for lateral indications) n Explicit indirect-decompression rationale, or a documented direct-decompression plan n Nicotine status + cessation counseling; bone-density status (subsidence risk) n Neuromonitoring plan and the identity/role of the monitoring professional n Planned levels; standalone vs. lateral-plate vs. posterior supplementation; interbody device; graft/biologic n Explicit surgeon medical-necessity statement and site-of-service rationale n Authorization number, criteria version, and approved code set on file
23
Coverage, Documentation & Operations
Procedure Comparison (When Applicable)
XLIF is one of several interbody approaches. The comparison below is operational, not a surgical selection guide; approach choice is the surgeon's clinical decision.
| Approach | Corridor / access | Operational notes |
| XLIF / LLIF | Lateral retroperitoneal, transpsoas | Code 22558; T12/L1-L4/5 (not L5-S1); mandatory neuromonitoring; lumbar-plexus risk; strong coronal correction & indirect decompression; off-label rhBMP-2 |
| Approach | Corridor / access | Operational notes |
| OLIF / ATP | Anterolateral (oblique, pre-psoas) | Also coded 22558; avoids transpsoas, reducing plexus risk; can approach L5-S1 in some variants |
| ALIF | Anterior retroperitoneal | Coded 22558; best L5-S1 access; access-surgeon & great-vessel considerations; on-label rhBMP-2 (single level) |
| TLIF | Posterior, transforaminal | Combined code 22633; direct decompression; posterior rhBMP-2 off-label |
| PLIF | Posterior, bilateral to disc | Straight interbody = 22630 |
| Decompression alone | Posterior, no fusion | Preferred when no instability; the payer-favored alternative in select degenerative spondylolisthesis |
ALIF, OLIF, TLIF, PLIF, and revision lumbar fusion are addressed in their own guides in the GoHealthcare MSK Specialty Procedure Library™.
24
GoHealthcare Operational Guidance
GoHealthcare Clinical Insights
Confirm the level is reachable. An XLIF request that lists L5-S1 as a lateral level is a documentation or intake error - the iliac crest generally precludes it; L5-S1 needs an anterior or posterior approach.
Make indirect decompression explicit. When no direct decompression is coded, state in the surgeon's words how disc-height restoration decompresses the symptomatic foramen/recess, supported by imaging.
Get the neuromonitoring right. IONM is separately reportable only by a dedicated professional; if the surgeon monitors, it is bundled. Clarify the arrangement before the case.
Plan for subsidence. Bone quality, cage footprint, expandable-device distraction, and supplemental fixation all bear on subsidence - document the strategy, especially in osteopenic patients.
25
GoHealthcare Operational Guidance
GoHealthcare Leadership Perspective
XLIF concentrates several operational challenges that reward disciplined process: a fusion code shared across approaches, a mandatory and separately governed neuromonitoring service, a level range that excludes L5-S1, and a decompression mechanism that is indirect and therefore easy to under-document. The 2026 elimination of the Inpatient-Only list for musculoskeletal procedures adds a site-of-service dimension - expanding ASC opportunity while requiring centers to prove neuromonitoring capability and model device-intensive economics before migrating cases.
The durable advantage is a criteria-mapped intake that captures XLIF's distinctive elements alongside the universal fusion requirements: instability or deformity documented, the target level confirmed accessible, the indirect-decompression rationale stated, the neuromonitoring arrangement clarified, and the conservative-care history itemized to the six-month lateral threshold. The same discipline that prevents denials protects the organization on compliance and supports clean, auditable revenue across both the fusion and the neuromonitoring claim. AI-enabled intake and criteria-matching tools accelerate this but amplify a sound process rather than replace the clinical judgment that anchors medical necessity.
26
GoHealthcare Operational Guidance
GoHealthcare Prior Authorization Insight
Two authorizations, not one. The fusion and the neuromonitoring may be adjudicated separately; confirm whether IONM needs its own authorization and who will bill it before the case.
Pre-empt the level question. State the specific levels and confirm lateral accessibility in the request; an unexplained L5-S1 lateral entry invites a pend.
Quantify everything. "Chronic pain, failed conservative treatment" is not reviewable. "6 months of PT, two injections with dated partial relief, ODI 44, grade 1 anterolisthesis with 4 mm translation at L3-4, coronal Cobb 22 degrees, planned indirect decompression" is.
Set up the indirect-decompression rationale. The single most XLIF-specific pend is a fusion without a decompression code and no stated mechanism; close that gap at intake.
27
GoHealthcare Operational Guidance
GoHealthcare Case Study
Clinical scenario. A patient in the seventh decade presents with progressive back and bilateral leg pain and a mild degenerative lumbar scoliosis, with foraminal narrowing and instability at L2-3 and L3-4 and preserved L5-S1.
Documentation challenges. The initial authorization packet led with pain severity, attached only supine MRI, listed "L2-S1" as planned lateral levels, described conservative care as "PT and injections" without dates, and did not state how the leg pain would be decompressed.
Prior authorization barriers. The delegated vendor pended the request citing (1) no dynamic imaging, (2) an unquantified conservative-care history, (3) L5-S1 listed as a lateral level (not accessible), and (4) no decompression rationale; a separate neuromonitoring authorization was also outstanding.
Payer considerations. The plan's criteria required instability on weight-bearing films or a defined deformity objective, a documented failed conservative-care course, and - because no direct decompression was planned - a clear indirect-decompression mechanism; IONM was governed by a separate policy.
Operational workflow. The authorization lead corrected the level list (lateral XLIF at L2-3 and L3-4; a separate plan for any L5-S1 work), obtained standing flexion/extension and coronal films (documenting translation and a Cobb angle), reconstructed a six-month conservative-care ledger, added a surgeon letter explaining coronal correction and indirect foraminal decompression via disc-height restoration, and confirmed a dedicated neuromonitoring professional for separate IONM reporting.
Resolution strategy. The rebuilt packet was resubmitted mapped line-by-line to the vendor's criteria, with the surgeon briefed for a two-minute peer-to-peer focused on instability, deformity, and the indirect-decompression mechanism; the IONM authorization was pursued in parallel.
Outcome. The fusion and neuromonitoring were approved without formal denials; the scheduled CPT® set (22558, +22585, +22853 per level, posterior supplemental instrumentation, graft, and IONM by a dedicated professional) and site of service matched the authorizations, and the claims adjudicated cleanly.
Lessons learned. The case turned on four XLIF-specific corrections: fixing an inaccessible level, documenting instability and deformity with the right imaging, stating the indirect-decompression mechanism, and setting up neuromonitoring as a separate, properly-attributed service.
28
GoHealthcare Operational Guidance
GoHealthcare Best Practices
n Adopt a single pre-submission fusion checklist mapped to each major vendor's criteria; make it mandatory intake. n Confirm lateral accessibility of every requested level (flag any L5-S1 lateral entry). n State the indirect-decompression mechanism whenever no direct decompression is coded. n Clarify the neuromonitoring arrangement and reporting professional before the case; pursue any separate IONM authorization. n Capture weight-bearing flexion/extension and, for deformity, coronal alignment films at the visit. n Align the conservative-care ledger with the six-month lateral-device / payer threshold. n Run a two-role QA (coder + clinical reviewer) before submission and again before the claim drops. n Re-verify site-of-service eligibility (22558 Addendum AA/B) and neuromonitoring capability per patient/payer/date.
29
Coverage, Documentation & Operations
Common Mistakes
n Listing L5-S1 as a lateral (XLIF) level. n Billing neuromonitoring (95940/95941/G0453) when the operating surgeon performed it (bundled), or without dedicated-professional/time documentation. n Reporting a lateral plate with posterior instrumentation codes (use anterior instrumentation 22845-22847), or vice versa. n Failing to document the indirect-decompression mechanism when no decompression is coded. n Submitting instability requests with supine imaging only; omitting coronal films for deformity. n Assuming rhBMP-2 is on-label for lateral fusion (it is on-label only for single-level anterior ALIF). n Using non-billable parent ICD-10 codes (e.g., M48.06) or imprecise scoliosis codes. n Assuming prior inpatient defaults still apply after the 2026 IPO changes.
30
GoHealthcare Operational Guidance
Pearls and Pitfalls
Pearls
n The lateral corridor is a coronal-correction and indirect-decompression tool - document those goals explicitly. n Neuromonitoring is integral to a safe transpsoas case and is a separate, professionally-attributed service. n Axial psoas/plexus assessment at L4-5 is part of safe selection, not an afterthought. n Pair XLIF with ALIF or a posterior technique when L5-S1 must be addressed.
Pitfalls
n Transpsoas approach-side morbidity (thigh pain/numbness, hip-flexor weakness) is common though usually transient - counsel and document. n Subsidence risk rises with osteopenia and over-distraction; plan fixation accordingly. n Indirect decompression is insufficient for high-grade central stenosis or sequestered fragments. n Site-of-service and neuromonitoring assumptions carried over from pre-2026 or from other approaches.
31
Coverage, Documentation & Operations
Frequently Asked Questions
What is the primary CPT® code for XLIF/LLIF?
22558 (anterior/anterolateral interbody arthrodesis, single lumbar interspace); +22585 for each additional interspace. There is no distinct lateral arthrodesis code - per NASS guidance, lateral approaches are reported with 22558.
Is XLIF coded the same as ALIF and OLIF?
Yes - all three use 22558. The specific corridor (anterior, lateral transpsoas, or oblique pre-psoas) is documented in the operative note, not distinguished by a different arthrodesis code.
How is the lateral interbody cage coded?
With the interbody biomechanical device add-on +22853 (device inserted in conjunction with interbody arthrodesis), reported per interspace.
How is a lateral plate coded versus posterior screws?
A lateral plate is reported with the anterior instrumentation codes (22845 for 2-3 vertebral segments, 22846 for 4-7, 22847 for 8+). Supplemental posterior pedicle-screw fixation uses the posterior instrumentation codes (e.g., 22840, 22842).
How is neuromonitoring coded, and who can bill it?
Intraoperative neuromonitoring is reported with +95940 (one-on-one in the operating room, per 15 minutes) and +95941 (remote/nearby; Medicare uses G0453). It is reportable only by a dedicated monitoring professional; if the operating surgeon or anesthesiologist performs it, it is bundled into the primary service. Modifiers TC/26 do not apply.
Why can't XLIF reach L5-S1?
The iliac crest blocks lateral access to L5-S1, and at that level the lumbar plexus and iliac vessels sit unfavorably for a lateral corridor. L5-S1 is typically addressed with an anterior (ALIF) or posterior approach.
What level range does XLIF cover?
Roughly T12/L1 through L4/5. L4-5 is the highest-risk lateral level because of plexus and vessel position, and should be planned with careful axial imaging.
Why is neuromonitoring necessary for XLIF?
The transpsoas corridor passes through the lumbar plexus within the psoas; neuromonitoring (EMG, often with MEP/SSEP) is used to reduce femoral-nerve and lumbar-plexus injury.
What is indirect decompression, and why does it matter for authorization?
Seating a tall interbody spacer restores disc and foraminal height, decompressing neural elements without a direct posterior decompression. Because no decompression code is reported, the surgeon must document the indirect mechanism so reviewers see how neural compression was addressed.
Does Medicare have an NCD for lumbar fusion?
No. Coverage is governed by MAC LCDs/articles, the OPPS/ASC framework, the Inpatient-Only transition, and the 2-midnight rule. Neuromonitoring has its own MAC coverage articles.
Did XLIF move off the Medicare Inpatient-Only list for 2026?
XLIF is reported with 22558, which was among the fusion codes CMS identified in the CY2026 musculoskeletal-first IPO phase-out for removal and ASC-CPL addition. Published summaries most often cite the posterior codes (22630/22633); confirm 22558's final OPPS Addendum B / ASC Addendum AA status at the date of service.
Which utilization-management vendors review lumbar fusion?
Commonly eviCore (CMM-609), Carelon, Cohere, Evolent, and TurningPoint, depending on the plan and product. Neuromonitoring is typically governed by a separate policy. Confirm the delegation before submitting.
How much conservative care is required before approval?
It varies - often a minimum of 6 weeks to 6 months. Lateral-device FDA labeling commonly references at least six months of non-operative treatment, so aligning to six months satisfies both the payer and the device label.
What imaging do payers expect?
MRI or CT establishing the pathology (with axial psoas/plexus assessment), weight-bearing flexion/extension films for instability, and coronal/alignment films when deformity correction is a goal.
Is fusion for degenerative disc disease covered?
Isolated degenerative disc disease / discogenic axial pain without instability or a defined reconstructive goal is the classic payer-scrutinized indication across CMS-aligned LCDs and most commercial policies.
Is rhBMP-2 (Infuse) on-label for XLIF?
No. Its FDA approval is limited to single-level anterior ALIF with a specified cage; lateral (transpsoas) use is off-label and payer-restricted - document rationale and consent if used.
What ICD-10 code is used for degenerative lumbar scoliosis?
The M41 series (e.g., M41.86 other forms of scoliosis, lumbar region), coded to the specific type and site; verify specificity against the documentation.
What are the XLIF-specific complications to counsel on?
Approach-side thigh pain or numbness, hip-flexor (psoas) weakness, and femoral / lumbar-plexus injury from the transpsoas corridor; most are transient but should be counseled and documented.
What are the most common denial reasons?
Insufficient/undated conservative care, no documented instability or deformity goal, missing dynamic/coronal imaging, an inaccessible (L5-S1) lateral level, an unjustified indirect-decompression rationale, neuromonitoring billed by the surgeon, and code/site mismatches.
How do I prevent a peer-to-peer review?
Front-load the packet against the vendor's criteria: instability or deformity documented, target level confirmed accessible, indirect-decompression rationale stated, conservative care itemized, neuromonitoring arrangement clarified, and a surgeon medical-necessity statement included.
How should site of service be documented in 2026?
State the clinical rationale for inpatient, HOPD, or ASC based on comorbidities, expected recovery, and safety, ensure the site supports neuromonitoring, and confirm the authorized site matches the claim; re-verify per payer and date of service.
32
Coverage, Documentation & Operations
Key Takeaways
n XLIF/LLIF is reported with 22558 (+22585 per additional level) - the same code as ALIF and OLIF; there is no distinct lateral arthrodesis code. n A lateral plate uses the anterior instrumentation codes (22845-22847); supplemental posterior fixation uses the posterior instrumentation codes. n Intraoperative neuromonitoring (+95940 / +95941 / G0453) is separately reportable only by a dedicated professional; if the surgeon monitors, it is bundled. TC/26 do not apply. n The lateral corridor reaches T12/L1-L4/5 but NOT L5-S1; pair with ALIF or a posterior technique for L5-S1. n Document the indirect-decompression mechanism whenever no direct decompression is coded - it is the most XLIF-specific necessity gap. n rhBMP-2 (Infuse) is off-label for lateral fusion (on-label only for single-level anterior ALIF). n For CY2026, 22558 was among the fusion codes CMS identified for IPO removal / ASC-CPL addition; confirm its final Addendum AA/B status at the date of service.
33
Coverage, Documentation & Operations
Future Outlook
Several trends will shape XLIF operations over the coming cycles:
n Site-of-service migration. With the IPO list phasing out and 22558 moving toward ASC eligibility, expect selected lateral fusions to shift toward outpatient/ASC settings - contingent on neuromonitoring capability, device-intensive payment modeling, and clinical readiness. n Prone and single-position lateral surgery. Prone lateral and single-position techniques (enabling same-position posterior fixation) are expanding, with implications for workflow, operative time, and how the combined construct is documented and coded. n Expandable and 3D-printed implants. Expandable lateral cages and porous titanium continue to develop to reduce subsidence and improve alignment, with device-intensive economics following. n Neuromonitoring evolution. Multimodal IONM (EMG plus MEP/SSEP) is increasingly standard; coverage scrutiny of remote/nearby monitoring and dedicated-professional requirements will persist.
n AI-enabled authorization. Payer-side automated review and provider-side criteria-matching tools will accelerate adjudication; the advantage accrues to practices whose documentation is already complete and criteria-mapped across both the fusion and neuromonitoring claims.
34
Policy, Evidence & Source Guidance
References
Authoritative sources; verify the current version and effective date of each before relying on it. URLs were active at the time of authorship.
- Centers for Medicare & Medicaid Services. Medicare Coverage Database (NCDs, LCDs, Articles), including IONM billing/coding
article A56722. https://www.cms.gov/medicare-coverage-database
- CMS. CY2026 Hospital OPPS and Ambulatory Surgical Center Payment System Final Rule (Inpatient-Only list phase-out; ASC
Covered Procedures List, Addendum AA). https://www.cms.gov/medicare/payment/prospective-payment-systems/hospital-outpatient
- LCD L37848, Lumbar Spinal Fusion (representative MAC LCD).
https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=37848
- eviCore by Evernorth. CMM-609: Lumbar Fusion (Arthrodesis) clinical guidelines.
https://www.evicore.com/provider/clinical-guidelines
- Carelon Medical Benefits Management. Spine Surgery Clinical Appropriateness Guidelines.
https://guidelines.carelonmedicalbenefitsmanagement.com
- Aetna. Clinical Policy Bulletin 0743, Spinal Surgery: Laminectomy and Fusion; CPB 0016, Interbody Fusion Devices.
https://www.aetna.com/cpb/medical/data/700_799/0743.html
- North American Spine Society (NASS). Coverage Policy Recommendations - Lumbar Fusion; coding guidance for interbody fusion
(including lateral approaches). https://www.spine.org
- American Association of Neurological Surgeons / Congress of Neurological Surgeons. Guideline update for fusion procedures for
degenerative lumbar spine disease, Part 11 (interbody techniques). https://www.cns.org
- Ozgur BM, Aryan HE, Pimenta L, et al. Extreme lateral interbody fusion (XLIF): a novel surgical technique for anterior lumbar
interbody fusion. Spine J. 2006;6(4):435-443. https://www.thespinejournalonline.com
- Oliveira L, Marchi L, Coutinho E, et al. A radiographic assessment of the ability of XLIF to indirectly decompress the neural
elements. Spine (Phila Pa 1976). 2010;35(26 Suppl):S331-S337. https://journals.lww.com/spinejournal
- Ghogawala Z, et al. Laminectomy plus fusion versus laminectomy alone for lumbar spondylolisthesis (SLIP). N Engl J Med.
2016;374(15):1424-1434. https://www.nejm.org
- Forsth P, et al. A randomized, controlled trial of fusion surgery for lumbar spinal stenosis. N Engl J Med. 2016;374(15):1413-1423.
- Austevoll IM, et al. Decompression with or without fusion in degenerative lumbar spondylolisthesis (NORDSTEN-DS). N Engl J Med.
2021;385(6):526-538. https://www.nejm.org
- U.S. Food & Drug Administration. Intervertebral body fusion device clearances (lateral systems) and rhBMP-2 (Infuse) labeling.
- American Medical Association. CPT® code set (current year), including Intraoperative Neurophysiology codes 95940-95941.
Build a Defensible, Scalable Procedure Workflow
GoHealthcare supports prior authorization, medical-necessity documentation, payer policy interpretation, coding and revenue integrity, appeals, and MSK specialty workflow design.
Developed By
Pinky Maniri
MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare A.I. Governance
Founder and Chief Executive Officer, GoHealthcare Practice Solutions
Educational and Operational Disclaimer
This content is provided for educational and operational planning purposes and is not medical, legal, coding, reimbursement, or payer-contract advice. Coverage, authorization, coding, payment, and clinical requirements vary by patient, plan, product, jurisdiction, Medicare Administrative Contractor, date of service, setting, and current policy. Verify the controlling source before scheduling, authorization, billing, appeal, or clinical decision-making. Authorization does not guarantee coverage or payment.